In people with type 2 diabetes and MASH, pioglitazone, a GLP-1 receptor agonist or a dual GIP and GLP-1 receptor agonist should be used for therapy, and resmetirom should be considered by a hepatologist with expertise in MASH and within the context of an interprofessional team approach [24]
While there are studies on the role of MTX-induced oxidative stress in liver and kidney damage (Reference Uraz, Tahan and Aygun5,Reference Jahovic, Cevik and Sehirli38Reference Moghadam, Tutunchi and Namvaran-Abbas-Abad40) , there is no study related to the effect of whey proteins on MTX-induced liver and kidney damage
Ben-Shachar D
We're holding our hearing in room 1200 at our swing space, 1021 O Street
Optum Rx is your trusted guide through the GLP1 era With a marketplace defined by complexity, rapid scientific progress and shifting policy, plan sponsors need expert guidance to help balance access, clinical integrity and financial sustainability